These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 2342229)
1. Behavioral effects of HR-592, a new derivative of indole. Gomita Y; Ichimaru Y; Moriyama M; Furuno K; Suemaru K; Osman FE; Araki Y Jpn J Pharmacol; 1990 Apr; 52(4):609-19. PubMed ID: 2342229 [TBL] [Abstract][Full Text] [Related]
2. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine. Tada M; Shirakawa K; Matsuoka N; Mutoh S Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological studies on triazine derivatives V Sedative and neuroleptic actions of 2-amino-4-[4-(2-hydroxyethyl)-piperazin-1-yl]-6-trifluoromethyl-s-triazine (TR-10). Tobe A; Kobayashi T Jpn J Pharmacol; 1976 Oct; 26(5):559-70. PubMed ID: 12393 [TBL] [Abstract][Full Text] [Related]
5. [Effects of suloctidil on the central and peripheral nervous systems]. Nishi H; Watanabe T; Mori M Nihon Yakurigaku Zasshi; 1983 Sep; 82(3):191-212. PubMed ID: 6319248 [TBL] [Abstract][Full Text] [Related]
6. [Behavioral pharmacology of mianserin hydrochloride, a new antidepressant (author's transl)]. Kamioka T; Sakai Y Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):533-47. PubMed ID: 7193623 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological actions of SM-9018, a new neuroleptic drug with both potent 5-hydroxytryptamine2 and dopamine2 antagonistic actions. Hirose A; Kato T; Ohno Y; Shimizu H; Tanaka H; Nakamura M; Katsube J Jpn J Pharmacol; 1990 Jul; 53(3):321-9. PubMed ID: 1975278 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacological studies of an antipschotic agent, penfluridol. (1). The central pharmacological actions]. Ito K; Nurimoto S; Shintomi K; Kowa Y; Yamamura M; Ishida R Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):795-813. PubMed ID: 828132 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system. Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097 [No Abstract] [Full Text] [Related]
10. In vitro and in vivo pharmacological profile of 4-(4-fluorobenzylidene)-1-[2-[5-(4-fluorophenyl)-1H-pyrazol-4-yl] ethyl] piperidine (NRA0161). Suzuki Y; Funakoshi T; Chaki S; Kawashima N; Ogawa S; Kumagai T; Nakazato A; Komurasaki T; Okuyama S Life Sci; 2002 Oct; 71(22):2603-15. PubMed ID: 12354579 [TBL] [Abstract][Full Text] [Related]
11. ["Methamphetamine-stereotypy and hypermotility" in rats chronically treated with reserpine--the effect of intracerebral injection of chlorpromazine]. Sano H; Totsuka Y; Furuuchi T; Sakai K; Koshikawa N; Shigehara R; Kobayashi M Nihon Yakurigaku Zasshi; 1982 Aug; 80(2):113-24. PubMed ID: 6890928 [TBL] [Abstract][Full Text] [Related]
12. Potentiation of cataleptogenic effects of neuroleptics by prostaglandins. Herman ZS; Słomińska-Zurek J; Kryk A; Kmieciak-Kołada K Pol J Pharmacol Pharm; 1978; 30(5):639-46. PubMed ID: 35782 [TBL] [Abstract][Full Text] [Related]
13. Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats. Jelovac N; Sikiric P; Rucman R; Petek M; Marovic A; Perovic D; Seiwerth S; Mise S; Turkovic B; Dodig G; Miklic P; Buljat G; Prkacin I Eur J Pharmacol; 1999 Aug; 379(1):19-31. PubMed ID: 10499368 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological study of [2-chloro-11-(2-dimethylaminoethoxy) dibenzo[b,f]thiepine] (zotepine), a new neuroleptic drug. Uchida S; Honda F; Otsuka M; Satoh Y; Mori J; Ono T; Hitomi M Arzneimittelforschung; 1979; 29(10):1588-94. PubMed ID: 42413 [TBL] [Abstract][Full Text] [Related]
15. Effects of mafoprazine, a phenylpiperazine derivative, on the central dopaminergic system. Yamamura M; Nakagawa H; Maeda K; Kinoshita K; Ishida R Jpn J Pharmacol; 1989 Jul; 50(3):295-305. PubMed ID: 2569544 [TBL] [Abstract][Full Text] [Related]
16. Behavioral pharmacologic studies in the monkey with DD-3480. Shibuya T; Nishimori T; Matsuda H; Chen PC Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):251-4. PubMed ID: 6125481 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo pharmacological profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562), a novel and putative atypical antipsychotic. Funakoshi T; Chaki S; Kawashima N; Suzuki Y; Yoshikawa R; Kumagai T; Nakazato A; Kameo K; Goto M; Okuyama S Life Sci; 2002 Aug; 71(12):1371-84. PubMed ID: 12127158 [TBL] [Abstract][Full Text] [Related]
18. [Behavioral pharmacology of amantadine with special references to the effect on abnormal behavior in mice and rats]. Fujiwara M; Sakurai Y; Kiyota Y; Shimazoe T; Ohta H; Shibata S; Ueki S Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):259-74. PubMed ID: 2989132 [TBL] [Abstract][Full Text] [Related]
19. Effects of HR-592, a new derivative of indole, on conditioned behavior. Ichimaru Y; Gomita Y; Araki Y; Moriyama M Acta Med Okayama; 1990 Feb; 44(1):35-9. PubMed ID: 2330844 [TBL] [Abstract][Full Text] [Related]
20. Effect of skimmianine on animal behavior. Cheng JT Arch Int Pharmacodyn Ther; 1986 May; 281(1):35-43. PubMed ID: 3753096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]